Loading...
Loading...
Knowledge resources whose private value to the institutional holder is declining — because the commercial window has closed, maintenance costs exceed returns, or organisational priorities have shifted — while their potential social value remains significant or growing.
A pharmaceutical company's failed Phase II clinical trial data: commercially worthless to the company, but the compound interaction records and patient population analyses could advance research in adjacent fields if released.
VUC Section 1